Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,781 total articles
Safe Pro Group Inc., a Nasdaq-listed AI defense technology firm, will demonstrate its NODE-X AI edge platform and SPOTD threat detection technology at the U.S. Army's 2026 Joint Protection Combined Expo. These advanced AI tools enable rapid drone image processing for mission planning, threat detection, 3D mapping, and enhanced battlefield situation…
Townsquare Media announced a strategic digital advertising partnership with North American Broadcasting Company (NABCO), extending its digital ad solutions to more large markets via NABCO's radio broadcast platforms. This partnership is part of Townsquare's Media Partnerships initiative under Townsquare Ignite, aiming to grow digital revenue and pr…
Avalyn Pharma has strengthened its leadership team by appointing Adam Golden as General Counsel and Head of Business Development, and Frank Salisbury as Senior Vice President of Commercial. These hires bring significant legal, business development, and commercial experience to support Avalyn's clinical advancement and upcoming transition to a publi…
Commerce (Nasdaq: CMRC) has introduced Feedonomics Agentic Catalog Exports (ACE), an enterprise service enabling merchants to syndicate optimized product catalogs to AI-powered agentic discovery platforms such as OpenAI and Google Gemini. This innovation supports enterprises in becoming 'agent-ready' for AI-driven shopping experiences, reducing eng…
Replimune Group, Inc. announced multiple oral and poster presentations for the upcoming 2026 ASCO Annual Meeting, highlighting key clinical trial results from their oncolytic immunotherapy candidates RP1 and RP2 in treating melanoma and advanced solid tumors. Notably, a 3-year overall survival analysis from the IGNYTE trial and final Phase 1 data o…
Magnite announced a significant upgrade of its AI-powered features in its SpringServe platform, introducing intelligent mediation tools such as anomaly detection, demand path optimization, and dynamic pricing to enhance media owners' monetization strategies. Concurrently, Magnite is advancing AI-driven buyer agent tools to streamline campaign activ…
Westwood Holdings Group announced a strategic partnership with ETF Capital Markets Advisors, led by industry veteran Nicholas Phillips, to optimize trading efficiency, liquidity, and execution quality across its ETF platform. This collaboration aims to deepen market maker and authorized participant relationships and improve investor outcomes throug…
Strive, Inc. has purchased an additional approximately 789 Bitcoin, bringing its total holdings to around 14,557 Bitcoin. The company also announced the 'Bitcoin for Business' summit in Lake Oswego, designed to educate CFOs and business leaders about Bitcoin's impact on corporate finance. Strive focuses on disciplined capital allocation with Bitcoi…
SBC Medical Group Holdings Incorporated announces the full rollout of its aesthetic healthcare interpretation app "Talk Bridge" across all Shonan Beauty Clinic locations. The initiative enhances English-speaking customer support with in-house interpretation services, the creation of the Global Beauty Advisor role, and upgraded English digital marke…
Global-e Online Ltd., a leading platform for global direct-to-consumer e-commerce, announced it will report its financial results for the first quarter ending March 31, 2026, before the market opens on May 13, 2026. The company will host a conference call and webcast to discuss the results and outlook.
Arcutis Biotherapeutics has submitted a supplemental New Drug Application to the FDA seeking approval to expand the indication of its topical therapy ZORYVE® (roflumilast) cream 0.05% to treat mild to moderate atopic dermatitis in infants aged 3 months to less than 24 months. This submission is supported by positive Phase 1 and Phase 2 clinical tri…
Belite Bio announced an upcoming oral presentation of positive topline results from its Phase 3 DRAGON trial evaluating tinlarebant for Stargardt disease type 1 (STGD1). Tinlarebant showed a significant 35.7% reduction in the growth of atrophic retinal lesions compared to placebo, with a strong safety profile. The therapy targets accumulation of bi…
Kratos Defense & Security Solutions, a Nasdaq-listed technology company serving defense and national security sectors, announced its first quarter 2026 earnings release and conference call scheduled for May 6th. Management will discuss financial results and operational updates, reflecting ongoing activities in defense technology and advanced system…
Humacyte, Inc. announced a virtual key opinion leader event to discuss its Acellular Tissue Engineered Vessel (ATEV) designed for arteriovenous (AV) access in hemodialysis patients. The event will feature leading experts discussing unmet medical needs, current treatment limitations with AV fistulas, and insights on clinical trials including an ongo…
Alpha Compute Corp. provided an update on its NVIDIA Blackwell GPU infrastructure deployments. The company is finalizing testing of its first large-scale GPU cluster (ALPHA-01) consisting of 504 NVIDIA B200 GPUs in Canada, targeting a May 8, 2026 go-live. Despite a delay from March due to supply chain issues, the deployment marks the transition fro…
Microchip Technology announced the opening of a new manufacturing facility in Tuscaloosa, Alabama dedicated to increasing production of its MHM-2020 Active Hydrogen Maser, a highly precise atomic clock used in critical infrastructure and scientific applications. The expansion is aimed at meeting rising global demand and reducing lead times while st…
Apollomics Inc. reported its full year 2025 financial results, highlighting significant progress in its oncology pipeline, particularly with its lead drug vebreltinib. The company is advancing global clinical trials for vebreltinib, a selective c-MET inhibitor approved in China for multiple indications, and plans to submit an IND application in the…
Terra Innovatum highlights the U.S. Nuclear Regulatory Commission's advancement of draft Part 57 rulemaking aimed at enabling efficient, scalable deployment of standardized microreactor systems. The Company’s SOLO™ Micro-Modular Reactor design aligns closely with the new risk-informed, performance-based licensing framework, positioning Terra Innova…
Opus Genetics announced that its leadership team will present encouraging preliminary and preclinical data on its gene therapy programs for inherited retinal diseases at multiple prestigious medical conferences in May 2026. This includes updates on Phase 1b/2a clinical trials for LCA5 and BEST1 gene therapies, highlighting advancements toward durab…
Cerence Inc., a leader in conversational AI for automotive and transportation, announced it will release its fiscal second quarter 2026 financial results on May 7, 2026. The company will host a live conference call and webcast to discuss results, inviting investors and analysts to participate. Cerence noted its strong position in the automotive AI …
FirstCash Holdings, Inc. announced that its wholly-owned subsidiary has commenced a private placement offering of $600 million aggregate principal amount of senior notes due 2034. The proceeds will be primarily used to repay outstanding borrowings under credit facilities, providing additional liquidity to fund future growth. The offering is targete…
OceanFirst Financial Corp. and Flushing Financial Corporation announced that they have received all necessary regulatory and shareholder approvals to complete their proposed merger. The merger is expected to close by June 1, 2026, combining two regional banks serving New Jersey and New York metropolitan markets. Both companies held shareholder meet…
Clearmind Medicine Inc., a clinical-stage biotech focused on non-hallucinogenic neuroplastogen therapies, announced it is evaluating its lead candidate CMND-100 (MEAI) for eligibility for the FDA's Breakthrough Therapy Designation based on positive Phase I/IIa clinical trial results in Alcohol Use Disorder. The designation could accelerate developm…
CADV Ventures S.A., a Poland-based AI software company specializing in AI-assisted IT support services, has entered into a business combination agreement with Miluna Acquisition Corp, a US-based SPAC listed on Nasdaq. Upon closing, the combined company will be named Kukugan Corp and listed on a national securities exchange, with an implied enterpri…
CorMedix Therapeutics reported positive topline results from the Phase III ReSPECT trial evaluating REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in adults undergoing allogeneic hematopoietic stem cell transplantation. The study met its primary endpoint, demonstrating non-inferiority to standard antimicrobial regimens for fu…
